TY - JOUR
T1 - Antioxidant therapy attenuates myocardial telomerase activity reduction in superoxide dismutase-deficient mice
AU - Makino, Naoki
AU - Maeda, Toyoki
AU - Oyama, Jun ichi
AU - Sasaki, Makoto
AU - Higuchi, Yoshihiro
AU - Mimori, Koji
AU - Shimizu, Takahiko
N1 - Funding Information:
We would like to thank Ms. K. Tsuchida, Ms. S. Taguchi, and Ms. Y. Ueda for their expert technical assistance. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science, and Culture of Japan .
PY - 2011/4
Y1 - 2011/4
N2 - Oxidative stress plays a pathological role in the development of heart failure. This study examined telomere biology in heart/muscle-specific manganese superoxide dismutase-deficient mice (H/M-SOD2-/-), which develop progressive congestive heart failure and exhibit pathology typical of dilated cardiomyopathy. EUK-8 (25mg/kg/day), a superoxide dismutase and catalase mimetic, was administered to H/M-SOD2-/- mice for four weeks beginning at 8weeks of age. Telomere length, telomerase activity, telomere-associated proteins, and cell death signals were assessed in hearts from control wild-type mice (H/M-Sod2 lox/ lox) and H/M-SOD2-/- mice either treated or untreated with EUK-8. While cardiac function was unchanged in these experimental mice, the end-diastolic dimension in H/M-SOD2-/- mice was notably dilated and could be significantly reduced by EUK-8 treatment. At the end of the study, no shortening of telomere length was observed in heart tissues from all mice tested, but telomerase activity was decreased in heart tissue from H/M-SOD2-/- mice compared to control mice. Protein expression for telomerase reverse transcriptase and telomere repeat binding factor 2 was also downregulated in H/M-SOD2-/- heart tissue as was expression of phospho-Akt, insulin-like growth factor, and endothelial nitric oxide synthase. Expression levels of Sirt1, a lifespan modulator, were enhanced while FoxO3a was depressed in H/M-SOD2-/- hearts. All of the changes seen in H/M-SOD2-/- heart tissue could be inhibited by EUK-8 treatment. Taken together, the results suggest that oxidant stress might affect myocardial telomerase activity and telomere-associated proteins. Telomerase may therefore play a pivotal role in antioxidant defense mechanisms, and may be useful as a novel therapeutic tool for treating human heart failure.
AB - Oxidative stress plays a pathological role in the development of heart failure. This study examined telomere biology in heart/muscle-specific manganese superoxide dismutase-deficient mice (H/M-SOD2-/-), which develop progressive congestive heart failure and exhibit pathology typical of dilated cardiomyopathy. EUK-8 (25mg/kg/day), a superoxide dismutase and catalase mimetic, was administered to H/M-SOD2-/- mice for four weeks beginning at 8weeks of age. Telomere length, telomerase activity, telomere-associated proteins, and cell death signals were assessed in hearts from control wild-type mice (H/M-Sod2 lox/ lox) and H/M-SOD2-/- mice either treated or untreated with EUK-8. While cardiac function was unchanged in these experimental mice, the end-diastolic dimension in H/M-SOD2-/- mice was notably dilated and could be significantly reduced by EUK-8 treatment. At the end of the study, no shortening of telomere length was observed in heart tissues from all mice tested, but telomerase activity was decreased in heart tissue from H/M-SOD2-/- mice compared to control mice. Protein expression for telomerase reverse transcriptase and telomere repeat binding factor 2 was also downregulated in H/M-SOD2-/- heart tissue as was expression of phospho-Akt, insulin-like growth factor, and endothelial nitric oxide synthase. Expression levels of Sirt1, a lifespan modulator, were enhanced while FoxO3a was depressed in H/M-SOD2-/- hearts. All of the changes seen in H/M-SOD2-/- heart tissue could be inhibited by EUK-8 treatment. Taken together, the results suggest that oxidant stress might affect myocardial telomerase activity and telomere-associated proteins. Telomerase may therefore play a pivotal role in antioxidant defense mechanisms, and may be useful as a novel therapeutic tool for treating human heart failure.
UR - http://www.scopus.com/inward/record.url?scp=79952071587&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952071587&partnerID=8YFLogxK
U2 - 10.1016/j.yjmcc.2010.12.014
DO - 10.1016/j.yjmcc.2010.12.014
M3 - Article
C2 - 21195081
AN - SCOPUS:79952071587
VL - 50
SP - 670
EP - 677
JO - Journal of Molecular and Cellular Cardiology
JF - Journal of Molecular and Cellular Cardiology
SN - 0022-2828
IS - 4
ER -